Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clozapine versus risperidone for cannabis craving in schizophrenia
NL-OMON21257Phase 3Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Aug 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in schizophrenia and cannabis use disorder (CUD) comparing Clozapine with Risperidone (2 arms). Primary endpoints: Pre-post change in craving-related brain activity, Subjective craving and 1 more. Planned start Aug 2008; status: not yet recruiting.
02
Drugs
clozapinerisperidone
03
Conditions
schizophreniacannabis use disorder (CUD)
Beyond the preview
Go deeper on NL-OMON21257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21257.